Sangamo Therapeutics (NASDAQ:SGMO) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Sangamo Therapeutics (NASDAQ:SGMO) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Sangamo Therapeutics (NASDAQ:SGMO - Get Free Report) issued its earnings results on Monday. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by ($0.12). Sangamo Therapeutics had a negative net margin of 331.28% and a negative return on equity of 813.95%. The firm had revenue of $14.23 million during the quarter, compared to the consensus estimate of $40.25 mil…